ORACLE INVESTMENT MANAGEMENT INC
Q1 2014 13F-HR Holdings
Net value change ($000)
+149,131
(20.5%)
New positions
9
Sold out positions
4
Turnover %
43.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Accelerate Diagnostics, Inc | 104,209 | NEW |
| THC | 75,172 | NEW |
| Hansen Medical Inc | 23,201 | 83.1% |
| *REPROS THERAPEUTICS INC | 22,039 | NEW |
| Acorda Therapeutics, Inc. | 17,041 | 29.8% |
| ENDOCYTE INC | 15,953 | NEW |
| NXSTAGE MEDICAL INC | 11,753 | 34.5% |
| IRWD | 10,193 | 81.2% |
| Transition Therapeutics Inc. | 9,790 | 40.2% |
| DERMA SCIENCES INC | 6,340 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| TENET HEALTHCARE CORP | -73,961 | -100.0% |
| ACCELERATE DIAGNOSTICS | -57,933 | -100.0% |
| THORATEC CORP | -12,971 | -17.1% |
| QUIDEL CORP /DE/ | -11,955 | -11.9% |
| GENTIVA HEALTH SVCS INC | -11,783 | -60.4% |
| *MAKO SURGICAL CORP | -4,542 | -100.0% |
| AGENUS INC | -3,236 | -100.0% |
| T | -3,012 | -13.9% |
| GTX INC DEL | -59 | -7.2% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | -18 | -3.4% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|